The Latest Breaking News from Depression

M&S worker sacked for confronting 'aggressive' man who refused to wear face mask

Deborah Daisy had not received training in dealing with crime and went off sick for five months with anxiety and depression caused by safety at work fears, a panel heard

Daily Mirror · Jul 12, 2022

Electrical eye stimulation could lead to ‘remarkable’ treatments for depression and dementia

Such a method could be better than invasive techniques like deep brain stimulation of the prefrontal cortex

The Independent UK · Jul 11, 2022

People with depression ‘stagnating’ in UK healthcare system

Research paints bleak picture in which huge numbers go undiagnosed and seriously ill people do not receive specialist care

The Guardian - UK · Jul 10, 2022

Love Island's Siannise Fudge praised as she speaks out on secret battle with depression

Love Island's Siannise Fudge has revealed how suffering from anxiety and depression behind closed doors led to her losing two stone in weight

Daily Mirror · Jul 4, 2022

Healing depression requires compassion

Last week, the hashtag #UrboyTJ appeared on Twitter after famous rapper Jirayut "Urboy TJ" Paloprakarn disappeared. Music fans and his friends were worried because he vanished after he posted on social media that he suffered from depression, was bipolar and was burnt out. In that post, Jirayut believed that nobody…

Bangkok Post · Jul 3, 2022

Former ITV Love Island star lost two stone after battling with depression and anxiety

Siannise Fudge was in tears after opening up about her struggle

Manchester Evening News · Jul 3, 2022

Can microdosing psychedelics improve your mental health? Here's what the science says

There’s been a lot of hype around microdosing psychedelics as a potential treatment for depression, anxiety and PTSD — but what does the research actually say about it?

ABC News · Jul 2, 2022

HC Wainwright Finds 'Synergies In Treatment' For This Bipolar-Focused Stock

HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA declined to issue an Emergency Use Authorization for NRx's Zyesami for a subgroup of patients who also received Gilead Sciences Inc's (NASDAQ:GILD) remdesivir in addition to Zyesami. The analyst is bullish on: Significant potential for NRX-101 for…

Benzinga · Jul 1, 2022

Researchers see hope for new and cheaper alternatives to anti-depressants

Research on the connection between the brain and the rest of the body may lead to cheaper and more effective ways to treat depression than anti-depressants.

The New Daily · Jul 1, 2022

Cannabis Can Help Alleviate Insomnia In Those Suffering From Depression & Anxiety, New Study Claims

According to new research published in BMC Psychiatry, cannabis can improve sleep in those suffering f

Benzinga · Jun 29, 2022